[TOVX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
30-Sep-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 5.22%
YoY- -43.63%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,443 -4,808 -7,016 -4,853 -4,968 -4,273 -5,263 2.27%
Tax -359 -330 -1,738 -152 -8 44 -13 819.19%
NP -5,084 -4,478 -5,591 -4,701 -4,960 -4,317 -5,263 -2.28%
Tax Rate - - - - - - - -
Total Cost 5,084 4,478 5,591 4,701 4,960 4,317 5,263 -2.28%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -8.38 -7.40 -8.89 -0.30 -0.31 -0.31 -0.40 664.20%
EPS Diluted -8.38 -7.40 -8.89 -0.30 -0.31 -0.31 -0.40 664.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.